TY  - JOUR
JF  - Modern scientific and technical research
Y1  - 2026/02/07/
AV  - public
SP  - 4
EP  - 12
N2  - The r?pid gr?wth in the number ?f di?betic p?tients ?nd ?ltern?tive insulin delivery meth?ds such ?s inh?l?ti?n ?r ?r?l ?dministr?ti?n b?sed ?n high d?ses ?re likely t? incre?se the dem?nd f?r rec?mbin?nt insulin in the ne?r future. Existing pr?ducti?n techn?l?gies c?nn?t meet the dem?nd f?r ?ff?rd?ble insulin due t? limited pr?ducti?n c?p?city ?nd high pr?ducti?n c?sts. This requires studying the mech?nisms ?f pr?ducti?n ?f ther?peutic rec?mbin?nt pr?teins. Rec?mbin?nt hum?n insulin is m?inly used f?r ther?peutic use ?f insulin pr?duced by E. c?li ?nd S?cch?r?myces cerevisi?e.
VL  - 1
A1  - Muhammadjon Mustafakulov
A1  - Abdumannon Uralov
A1  - Dilyorbek Ganijanov
A1  - Bobur Anvarov
A1  - T?shbek?v Nurmuh?mm?d
UR  - https://arxiv.publishscience.uz/1170/
IS  - 2
ID  - arxiv1170
TI  - TECHN?L?GY ?F GENETIC ENGINEERING ?F INSULIN FR?M MICR??RG?NISMS
ER  -